Two Sigma Investments
CRL icon

Two Sigma Investments’s Charles River Laboratories CRL Stock Holding History

Two Sigma Investments’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-7,600
Closed -$2.86M – 2990
2021
Q4 		$2.86M Buy
7,600
+6,700
+744% +$2.6M 0.01% 1609
2021
Q3 		$371K Buy
+900
New +$374K ﹤0.01% 3502

Other funds holding CRL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Two Sigma Investments's CRL Position: Q1 2026 in Review

Two Sigma Investments reduced its Charles River Laboratories (CRL) stake by 27% in Q1 2026, selling an estimated $1.39M and leaving 20,623 shares worth $3.56M. The position accounts for ﹤0.01% of the portfolio, ranked #2293.

Two Sigma Investments first reported a position in CRL in Q2 2013 and has held it in 44 quarters since. The position peaked at $74.1M in Q1 2022. 558 funds tracked by Wall St. Rank hold CRL as of Q1 2026.

  • Two Sigma Investments held 20,623 shares of Charles River Laboratories worth $3.56M as of Q1 2026.
  • Two Sigma Investments sold 7,482 Charles River Laboratories shares in Q1 2026, an estimated $1.39M.
  • Charles River Laboratories made up ﹤0.01% of Two Sigma Investments's portfolio in Q1 2026, its #2293 holding.
  • Two Sigma Investments first reported a position in Charles River Laboratories in Q2 2013 and has held it in 44 quarters since.
  • Two Sigma Investments's Charles River Laboratories position peaked at $74.1M in Q1 2022.
  • 558 funds tracked by Wall St. Rank held Charles River Laboratories as of Q1 2026.

Based on Two Sigma Investments's 13F filing for Q1 2026, filed 15 May 2026.